Centricity Research Vaughn Endocrinology
Concord, Ontario L4K 4M2
0 studies enrolling now · 2 studies all time
What they study most
Chronic Kidney Disease, Obesity, Type 2 Diabetes, Type 2 Diabetes Mellitus
Studies at this site
- A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor — Completed
- A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo — Completed